Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopy

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5880-5887

  Schlichtenbrede, Frank C ^a   Mittmann, Wolfgang ^b   Rensch, Florian ^a   Hagen, Franziska Vom ^a   Jonas, Jost B ^a   Euler, Thomas ^b  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; N METHYL DEXTRO ASPARTIC ACID; RHODAMINE; SULFORHODAMINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; COLORING AGENT; DIAGNOSTIC AGENT; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID; MONOCLONAL ANTIBODY; N METHYLASPARTIC ACID; SULFORHODAMINE 101;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EXPOSURE; EXPLANT; GLIA CELL; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA INJURY; TWO PHOTON MICROSCOPY; ANIMAL; ANIMAL MODEL; C57BL MOUSE; CELL COUNT; DRUG EFFECT; INJECTION; METABOLISM; METHODOLOGY; MULTIPHOTON MICROSCOPY; NICK END LABELING; PATHOLOGY; PILOT STUDY; RETINA; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL COUNT; COLORING AGENTS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOIDS; IN SITU NICK-END LABELING; INJECTIONS; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; MODELS, ANIMAL; N-METHYLASPARTATE; PILOT PROJECTS; RETINA; RHODAMINES; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 73349140202     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3078     Document Type: Article

References (32)

1. Jonas JB. Intravitreal triamcinolone acetonide: a change in a paradigm. Ophthalmic Res. 2006;38:218-245.
2. Jonas JB, Spandau UH, Schlichtenbrede F. Short-term complications of intravitreal injections of triamcinolone and bevacizumab. Eye. 2008;22:590-591.
3. Jonas JB. Intravitreal triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol. 2007;39:96-110.
4. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 2007;18:502-508.
5. Joussen AM, Weiss C, Bauer D, Hilgers RD. Triamcinolone versus inner-limiting membrane peeling in persistent diabetic macular edema (TIME study): design issues and implications. Graefes Arch Clin Exp Ophthalmol. 2007;245:1781-1787.
6. Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence microscopy. Science. 1990;248:73-76.
7. Denk W, Detwiler PB. Optical recording of light-evoked calcium signals in the functionally intact retina. Proc Natl Acad Sci USA. 1999;96:7035-7040.
8. Euler T, Hausselt SE, Margolis DJ, et al. Eyecup scope-optical recordings of light stimulus-evoked fluorescence signals in the retina. Pflugers Arch. 2009;457:1393-1414.
9. Spandau UH, Derse M, Schmitz-Valckenberg P, et al. Triamcinolone acetonide concentration after filtration of the solvent agent. Am J Ophthalmol. 2005;139:712-713.
10. Rutland CS, Mitchell CA, Nasir M, Konerding MA, Drexler HC. Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter. Mol Vis. 2007;13:47-56.
11. Remtulla S, Hallett PE. A schematic eye for the mouse, and comparisons with the rat. Vision Res. 1985;25:21-31.
12. Kwong JM, Lam TT. N-methyl-D-aspartate (NMDA) induced apoptosis in adult rabbit retinas. Exp Eye Res. 2000;71:437-444.
13. Denk W, Piston DW, Webb WW. Two-photon molecular excitation in laser-scanning microscopy. In: Pawley JB, ed. Handbook of Biological Confocal Microscopy. New York: Plenum Press; 1995; 445-458.
14. Denk W, Svoboda K. Photon upmanship: why multiphoton imaging is more than a gimmick. Neuron. 1997;18:351-357.
15. Weng S, Sun W, He S. Identification of ON-OFF direction-selective ganglion cells in the mouse retina. J Physiol. 2005;562:915-923.
16. Pyle JL, Kavalali ET, Choi S, Tsien RW. Visualization of synaptic activity in hippocampal slices with FM1-43 enabled by fluorescence quenching. Neuron. 1999;24:803-808.
17. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci. 1998;18:8936-8946.
18. Euler T, Detwiler PB, Denk W. Directionally selective calcium signals in dendrites of starburst amacrine cells. Nature. 2002;418: 845-852.
19. Oesch N, Euler T, Taylor WR. Direction-selective dendritic action potentials in rabbit retina. Neuron. 2005;47:739-750.
20. Hausselt SE, Euler T, Detwiler PB, Denk W. A dendrite-autonomous mechanism for direction selectivity in retinal starburst amacrine cells. PLoS Biol. 2007;5:185.
21. Margolis DJ, Newkirk G, Euler T, Detwiler PB. Functional stability of retinal ganglion cells after degeneration-induced changes in synaptic input. J Neurosci. 2008;28:6526-6536.
22. Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res. 2007;84:342-348.
23. Lang Y, Zemel E, Miller B, Perlman I. Retinal toxicity of intravitreal kenalog in albino rabbits. Retina. 2007;27:778-788.
24. Garcia-Arumi J, Boixadera A, Giralt J, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol. 2005;89:1112-1114.
25. Kai W, Yanrong J, Xiaoxin L. Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density. Graefes Arch Clin Exp Ophthalmol. 2006;244:1152-1159.
26. Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006;47: 722-728.
27. Luke M, Januschowski K, Beutel J, et al. The effects of triamcino-lone crystals on retinal function in a model of isolated perfused vertebrate retina. Exp Eye Res. 2008;87:22-29.
28. Szurman P, Sierra A, Kaczmarek R, et al. Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res. 2007;85:44-53.
29. Kaempf S, Johnen S, Salz AK, Weinberger A, Walter P, Thumann G. Effects of bevacizumab (Avastin) on retinal cells in organotypic culture. Invest Ophthalmol Vis Sci. 2008;49:3164-3171.
30. Lichtman JW, Wilkinson RS, Rich MM. Multiple innervation of tonic endplates revealed by activity-dependent uptake of fluorescent probes. Nature. 1985;314:357-359.
31. Ogilvy CS, Borges LF. A quantitative analysis of the retrograde axonal transport of 4 different fluorescent dyes in peripheral sensory and motor neurons and lack of anterograde transport in the corticospinal system. Brain Res. 1988;475:244-253.
32. Nimmerjahn A, Kirchhoff F, Kerr JN, Helmchen F. Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo. Nat Methods. 2004;1:31-37.